96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

19 trials found

diseases per page:

Showing 1 to 10 of 19 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005770-99-NO (EUCTR)	20/01/2022	23/09/2021	A study to test whether spesolimab helps people with Crohn’s disease who have symptoms of bowel obst ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab ( ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim Norway KS	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Portugal;Serbia;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Denmark ...
2	EUCTR2020-005770-99-IT (EUCTR)	24/11/2021	28/09/2021	A study to test whether spesolimab helps people with Crohn's disease whohave symptoms of bowel obstr ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trialto evaluate spesolimab (B ...	Fibrostenotic Crohn's Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Name: BI 655130 Product Code: [BI 655130] INN or Proposed INN: SPESOLIMAB	BOEHRINGER-INGELHEIM ITALIA S.P.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	Serbia;United States;Portugal;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Aruba;A ...
3	EUCTR2020-005770-99-NL (EUCTR)	12/11/2021	05/08/2021	A study to test whether spesolimab helps people with Crohn’s disease who have symptoms of bowel obst ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab ( ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Serbia;Portugal;Taiwan;Hong Kong;Spain;Ireland;Israel;Italy;Switzerland;France;Denmark ...
4	NCT05013385 (ClinicalTrials.gov)	November 9, 2021	13/8/2021	A Study to Test Whether Spesolimab Helps People With Crohn's Disease Who Have Symptoms of Bowel Obst ...	Multi-center, Double-blind, Randomized, Placebo-controlled, Phase IIa Trial to Evaluate Spesolimab ( ...	Fibrostenotic Crohn´s Disease	Drug: Spesolimab;Drug: Placebo	Boehringer Ingelheim	NULL	Recruiting	18 Years	75 Years	All	100	Phase 2	Austria;Belgium;Canada;Germany;Korea, Republic of;Netherlands;Norway;Sweden
5	EUCTR2020-005770-99-IE (EUCTR)	09/11/2021	30/07/2021	A study to test whether spesolimab helps people with Crohn’s disease who have symptoms of bowel obst ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab ( ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim Ltd	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Serbia;Portugal;Taiwan;Hong Kong;Spain;Ireland;Israel;Italy;Switzerland;France;Denmark ...
6	EUCTR2020-005770-99-SE (EUCTR)	20/10/2021	02/09/2021	A study to test whether spesolimab helps people with Crohn’s disease who have symptoms of bowel obst ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab ( ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Portugal;Serbia;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Denmark ...
7	EUCTR2020-005770-99-DK (EUCTR)	22/09/2021	20/08/2021	A study to test whether spesolimab helps people with Crohn’s disease who have symptoms of bowel obst ...	Multi-center, double-blind, randomized, placebo-controlled, phase IIa trial to evaluate spesolimab ( ...	Fibrostenotic Crohn’s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Croh ...	Product Code: BI 655130 INN or Proposed INN: SPESOLIMAB	Boehringer Ingelheim B.V	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 2	United States;Portugal;Serbia;Taiwan;Hong Kong;Spain;Ireland;Israel;Switzerland;Italy;France;Austral ...
8	EUCTR2019-001673-93-ES (EUCTR)	23/04/2021	09/02/2021	A study to test long-term treatment with spesolimab in patients with fistulising Crohn’s disease who ...	An open label, long term safety trial of spesolimab treatment in patients with fistulising Crohn’s d ...	Crohns disease MedDRA version: 20.0;Level: LLT;Classification code 10011408;Term: Crohns disease agg ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 2	Hungary;Belgium;Spain;Denmark;Austria;Netherlands;Germany;Korea, Republic of
9	EUCTR2019-001673-93-BE (EUCTR)	19/01/2021	23/11/2020	A study to test long-term treatment with spesolimab in patients with fistulising Crohn’s disease who ...	An open label, long term safety trial of spesolimab treatment in patients with fistulising Crohn’s d ...	Crohns disease MedDRA version: 20.0;Level: LLT;Classification code 10011408;Term: Crohns disease agg ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	20	Phase 2	Hungary;Spain;Belgium;Denmark;Austria;Netherlands;Germany;Korea, Republic of
10	EUCTR2017-003090-34-DK (EUCTR)	12/11/2020	15/06/2020	A study testing how BI 655130 works in patients with fistulizing Crohn’s Disease	Mechanism of Action and Clinical Effect of BI 655130in Patients with fistulizing Crohn’s Disease - B ...	Fistulizing Crohn’s Disease MedDRA version: 20.0;Level: LLT;Classification code 10075465;Term: Fistu ...	Product Code: BI 655130 INN or Proposed INN: Spesolimab Other descriptive name: MONOCLONAL ANTIBODY AN ...	Boehringer Ingelheim BV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	28	Phase 2	Denmark;Netherlands;Germany;Korea, Republic of;Hungary;Spain;Belgium;Austria

First Previous1 2Next Last